Pfizer Stock Dips as Q2 Earnings Expected to Show Steep Declines
-
Pfizer (PFE) stock dropped 0.21% while broader markets gained as investors look to upcoming earnings release expected to show steep decline in EPS and revenue.
-
Pfizer earnings per share projected to decrease 114% year-over-year to a loss of $0.16 per share.
-
Revenue for Pfizer expected to drop nearly 40% versus last year to $14.58 billion.
-
Full year guidance calls for 76.6% drop in EPS to $1.54 per share and a 41.37% revenue decline to $58.83 billion.
-
Pfizer stock trades at forward P/E ratio of 18.56, representing premium versus industry average of 15.47.